Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?

To: Manny Gugliuzza who wrote (282)	3/16/1998 7:53:00 PM
From: Robert DeHaven	Read Replies (1) \| Respond to of 1510

I spoke to a few IMNR followers today and the company was recently involved in some litigation involving their Reumatoid drug....I don't know this for fact but someone mentioned it to me stating that the outcome was finalized and was a positive for IMNR...this could partly explain the strength shown recently. The stock is under accumulation for the time being though ad with any further positive developments should be at 13 plus fairly quickly....I am hoping anyway....but confident. good luck, bob